GenomOncology collaborates with Glioblastoma Foundation to speed up glioblastoma brain cancer treatment: Cleveland Thursday, November 13, 2025, 11:00 Hrs [IST] GenomOncology, a gl ...
GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation's most aggressive brain cancer, glioblastoma. The collaboration ...
AZoLifeSciences on MSN

Why Is Drug Discovery So Difficult?

This article addresses the high failure rates in drug development, offering insights on improving clinical trials through AI ...
Approximately $137.2 million (US$100.0 million) was outstanding as of the end of Q3 2025 under the Appian 2025 Financing Facility (as defined herein) following the initial draw. $4.4 million in ...
The games industry has long been a test bed for innovation. Computer graphics, scanning, hardware acceleration with CPUs and ...
Take the best free IQ test online with free instant results at BestIQTest.org - a legitimate, science-based IQ testing platform offering accurate, trusted, and reliable intelligence assessments for ...
"MF200 represents the next evolution in smart veterinary testing — a compact solution that truly redefines diagnostic efficiency," said Li Ming, CEO of KHB Group. "Our goal is to empower veterinary ...
Management practices in regenerative ag focus on minimal soil disturbance, integration of cover crops and increasing ...
Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market s | Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease ...
Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics.
Anteros Metals Inc. (CSE: ANT) (“Anteros” or the “Company”) is pleased to report results from its first channel ...